PPARG Protein (AA 349-488)

N° du produit ABIN8128949

Protéine Recombinant PPARG exprimée dans Escherichia coli (E. coli).

Aperçu rapide pour PPARG Protein (AA 349-488) (ABIN8128949)

Antigène: PPARG (Peroxisome Proliferator-Activated Receptor gamma (PPARG))

Type de proteíne: Recombinant

Activité biologique: Active

Origine: Humain

Source: Escherichia coli (E. coli)

Application: Activity Assay (AcA), Cell Culture (CC)

Pureté: > 90 %

Détail du produit

Attributs du protein: AA 349-488

Fonction: Active Peroxisome Proliferator Activated Receptor Gamma (PPARg)

Séquence: Gly349-Glu488

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Commentaires:

STABILITY: The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Isoelectric Point: 5.8

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Reconstitute in 10 mM PBS ( pH 7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

Buffer: PBS, pH 7.4, containing 0.01 % SKL, 1 mM DTT, 5 % Trehalose and Proclin300.

Agent conservateur: Dithiothreitol (DTT), ProClin

Précaution d'utilisation: This product contains ProClin and Dithiothreitol (DTT): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.

Stock: 4 °C,-80 °C

Stockage commentaire: Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Détail du antigène

Antigène: PPARG (Peroxisome Proliferator-Activated Receptor gamma (PPARG))

Autre désignation: Peroxisome Proliferator Activated Receptor Gamma

Sujet: PPAR-G, PPARG1, PPARG2, NR1C3, Glitazone Receptor, Nuclear Receptor Subfamily 1 Group C Member 3

Poids moléculaire: 16kDa

UniProt: P37231

Pathways: Signalisation MAPK, Nuclear Receptor Transcription Pathway, Steroid Hormone Mediated Signaling Pathway, Negative Regulation of Hormone Secretion, Carbohydrate Homeostasis, Regulation of Lipid Metabolism by PPARalpha, Positive Regulation of Endopeptidase Activity, Brown Fat Cell Differentiation, Positive Regulation of fat Cell Differentiation